Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037463 · ClinicalTrials.gov registry record
Measuring Parkinson's Disease With Tear Fluid
A clinical trial, sponsored by University of Southern California.
- Completed
- Registry status
- 205
- Enrollment target
NCT03037463: Completed study, sponsored by University of Southern California.
NCT03037463 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 205 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03037463 has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- 205 participants
- Enrollment target
Study Summary
The purpose of this study is to assess whether tear secretion in patients with Parkinson's disease will be altered to exhibit a characteristic or diagnostic biomarker profile, that will be reflected in changes in the protein composition of tear fluid, which can be measured relatively easily, cost-effectively, and non-invasively. Tear fluid samples will be collected from Parkinson's patients, and through biochemical assays, the profile of proteins in tears will be characterized and compared to that from control subjects. The profiles will be analyzed with respect to any differences between Parkinson's patients and control subjects. If differences appear, the levels of these potential biomarkers in Parkinson's patients will be compared to the severity of their disease.
Primary Outcome
4 potential biomarkers will be evaluated in collected tear fluid and will be followed longitudinally for 3-4 visits
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 205 participants |
| Start Date | 2017-01 |
| Est. Completion | 2022-03 |
What the finished NCT03037463 record still lists
NCT03037463 is an observational study that tracks outcomes without assigning an intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03037463 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03037463 about?
NCT03037463 is a clinical study titled "Measuring Parkinson's Disease With Tear Fluid". The purpose of this study is to assess whether tear secretion in patients with Parkinson's disease will be altered to exhibit a characteristic or diagnostic biomarker profile, that will be reflected in changes in the protein composition of tear fluid, which can be measured relatively easily, cost-ef...
What is the current status of trial NCT03037463?
This trial is currently completed. The enrollment target is 205 participants. The study started on 2017-01. Estimated completion is 2022-03.
Who is sponsoring clinical trial NCT03037463?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03457493 · 205 participants · Phase 1
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
- NCT05134857 · 205 participants · Phase 2
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
- NCT05181891 · 205 participants · Phase 2
Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking
- NCT05283811 · 205 participants · NA
Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia